American businessman
Arrakis is developing RNA-targeted small molecule (rSM) therapies to millions of patients.
NanoString Technologies is a biotechnology company developing diagnostic tools for cancer founded in 2003.
A biotechnology startup company that develops messenger RNA based therapeutics to treat diseases.